Research Article
Identification of Potential Therapeutic Targets in the Liver of Pioglitazone-Treated Type 2 Diabetes Sprague-Dawley Rats via Expression Profile Chip and iTRAQ Assay
Figure 1
Pioglitazone reduces the fasting blood glucose level of DM rats. The fasting blood glucose levels in rats were significantly reduced after treatment with pioglitazone. , the DM model group compared with the control group; , the DM model group compared with the pioglitazone-treated group.